These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11442144)
1. On the association between valproate and polycystic ovary syndrome: a response and an alternative view. Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144 [No Abstract] [Full Text] [Related]
2. Valproate and the polycystic ovarian syndrome: final thoughts. Herzog AG; Schachter SC Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145 [No Abstract] [Full Text] [Related]
3. Valproate and polycystic ovaries. Eberle AJ J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1009. PubMed ID: 9785710 [No Abstract] [Full Text] [Related]
4. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510 [No Abstract] [Full Text] [Related]
10. Polycystic ovarian syndrome in women with epilepsy: a review. Duncan S Epilepsia; 2001; 42 Suppl 3():60-5. PubMed ID: 11520327 [TBL] [Abstract][Full Text] [Related]
11. Valproate, hyperandrogenism, and polycystic ovaries: a report of 3 cases. Isojarvi JI; Tapanainen JS Arch Neurol; 2000 Jul; 57(7):1064-8. PubMed ID: 10891991 [TBL] [Abstract][Full Text] [Related]
12. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460 [TBL] [Abstract][Full Text] [Related]
13. Long-term reproductive endocrine health in young women with epilepsy during puberty. Mikkonen K; Vainionpää LK; Pakarinen AJ; Knip M; Järvelä IY; Tapanainen JS; Isojärvi JI Neurology; 2004 Feb; 62(3):445-50. PubMed ID: 14872028 [TBL] [Abstract][Full Text] [Related]
14. On the association between valproate and polycystic ovary syndrome. Genton P; Bauer J; Duncan S; Taylor AE; Balen AH; Eberle A; Pedersen B; Salas-Puig X; Sauer MV Epilepsia; 2001 Mar; 42(3):295-304. PubMed ID: 11442143 [TBL] [Abstract][Full Text] [Related]
15. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Isojärvi JI; Rättyä J; Myllylä VV; Knip M; Koivunen R; Pakarinen AJ; Tekay A; Tapanainen JS Ann Neurol; 1998 Apr; 43(4):446-51. PubMed ID: 9546324 [TBL] [Abstract][Full Text] [Related]
16. More on valproate and polycystic ovaries. Johnston HF J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101 [No Abstract] [Full Text] [Related]
17. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy. Gorkemli H; Genc BO; Dogan EA; Genc E; Ozdemir S Gynecol Obstet Invest; 2009; 67(4):223-7. PubMed ID: 19246930 [TBL] [Abstract][Full Text] [Related]
18. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Luef G; Abraham I; Trinka E; Alge A; Windisch J; Daxenbichler G; Unterberger I; Seppi K; Lechleitner M; Krämer G; Bauer G Epilepsy Res; 2002 Jan; 48(1-2):91-102. PubMed ID: 11823113 [TBL] [Abstract][Full Text] [Related]
19. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. O'Donovan C; Kusumakar V; Graves GR; Bird DC J Clin Psychiatry; 2002 Apr; 63(4):322-30. PubMed ID: 12000206 [TBL] [Abstract][Full Text] [Related]
20. Obesity and endocrine disorders in women taking valproate for epilepsy. Isojärvi JI; Laatikainen TJ; Knip M; Pakarinen AJ; Juntunen KT; Myllylä VV Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]